SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
Imaging Technology
OCTOBER 11, 2023
milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP).
Let's personalize your content